DEF 14A
Jean-Pierre Sommadossi, Ph.D.
Sommadossi Jean-Pierre Increases Position in Atea Pharmaceuticals (AVIR) | Nasdaq
Atea Pharmaceuticals to Present at the 41st Annual J.P.
On the Move: Personnel moves in the Mass. life sciences industry - Boston Business Journal
thebenefactor
CCCC , ASAP Articles, css200810347 | Collection of Czechoslovak Chemical Communications
中華民國製藥發展協會
Jean-Pierre Sommadossi - Director at Kezar Life Sciences | The Org
Jean-Pierre Sommadossi, Founder, Chief Executive Officer and Chairman, Atea Pharmaceuticals
Jean-Pierre Sommadossi's research works | Boston Pharmaceuticals, Cambridge and other places
CORPORATE FACT SHEET
11 | janvier | 2013 | Café des Sciences de Boston
Jean-Pierre Sommadossi, Atea Pharmaceuticals Inc: Profile and Biography - Bloomberg Markets
Jean-Pierre Sommadossi, chairman and chief executive of Idenix... News Photo - Getty Images
Jean-Pierre Sommadossi's research works | Boston Pharmaceuticals, Cambridge and other places
Jean-Pierre Sommadossi, PhD - Atea Pharmaceuticals
Our Team - Atea Pharmaceuticals
![Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]](https://uspto.report/patent/app/20200331956/US20200331956A1-20201022-C00001.png "Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]")
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]
BioCentury - Roche in $350M deal with Sommadossi's Atea for what it believes could be first oral COVID-19 antiviral
Jean-Pierre Sommadossi - Director at Kezar Life Sciences | The Org
![Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]](https://uspto.report/patent/app/20200331956/US20200331956A1-20201022-C00002.png "Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-2-modified-n6-substi- Tuted Purine Nucleotides For Hcv Treatment Sommadossi; Jean-Pierre ; et al. [Atea Pharmaceuticals, Inc.]")